title: [Endomyocardial biopsy following heart transplantation: results and complications].
abstract: Heart transplantation (HTPL) has worldwide become a well established therapy of terminal heart failure. Besides non-invasive parameters the endomyocardial biopsy (EMB) is proved to be the goldstandard method for early detection of graft rejection. At the University Hospital of Zurich 31 HTPL have been performed between September 1985 and December 1987. 100 out of 460 EMB's showed moderate or severe rejection and needed additional immunosuppressive treatment. 1.5% of all EMB's caused further treatment due to local or systemic complications.
authors.forename: M
authors.initials: M
authors.lastname: Furrer
authors.forename: K
authors.initials: K
authors.lastname: Schneider
authors.forename: A
authors.initials: A
authors.lastname: Gallino
authors.forename: J
authors.initials: J
authors.lastname: Schneider
authors.forename: P
authors.initials: P
authors.lastname: Vogt
authors.forename: M
authors.initials: M
authors.lastname: Turina
mesh_terms: D001706:Biopsy; D004699:Endocardium / Q000473:pathology*; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D009206:Myocardium / Q000473:pathology*; D011183:Postoperative Complications / Q000473:pathology*
vernacular_title: Endomyokardbiopsie nach Herztransplantation: Resultate und Komplikationen.